Strategy Asset Managers LLC Invests $2.68 Million in UnitedHealth Group Inc (UNH)

Strategy Asset Managers LLC purchased a new position in UnitedHealth Group Inc (NYSE:UNH) in the 3rd quarter, Holdings Channel reports. The firm purchased 13,668 shares of the healthcare conglomerate’s stock, valued at approximately $2,677,000.

Several other hedge funds have also bought and sold shares of UNH. Jennison Associates LLC grew its holdings in shares of UnitedHealth Group by 146.0% in the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after acquiring an additional 3,289,470 shares during the period. Harbour Capital Advisors LLC grew its holdings in shares of UnitedHealth Group by 18,383.4% in the second quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock worth $13,573,000 after acquiring an additional 2,503,090 shares during the period. Janus Henderson Group PLC grew its holdings in shares of UnitedHealth Group by 1,820.1% in the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after acquiring an additional 2,264,242 shares during the period. Vanguard Group Inc. grew its holdings in shares of UnitedHealth Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares during the period. Finally, Parametric Portfolio Associates LLC grew its holdings in shares of UnitedHealth Group by 77.3% in the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after acquiring an additional 1,562,661 shares during the period. Hedge funds and other institutional investors own 86.01% of the company’s stock.

UnitedHealth Group Inc (NYSE UNH) opened at $228.64 on Friday. The firm has a market capitalization of $221,060.00, a PE ratio of 25.98, a PEG ratio of 1.57 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group Inc has a one year low of $156.09 and a one year high of $231.77.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The firm had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.17 earnings per share. research analysts forecast that UnitedHealth Group Inc will post 9.99 EPS for the current year.

Several brokerages recently commented on UNH. Evercore ISI reaffirmed an “outperform” rating and issued a $255.00 price objective (up previously from $235.00) on shares of UnitedHealth Group in a report on Friday. Goldman Sachs Group began coverage on UnitedHealth Group in a report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price objective for the company. Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $235.00 price objective on shares of UnitedHealth Group in a report on Monday, December 25th. Finally, ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th. Three equities research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $229.54.

In related news, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at $43,310,879.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,630 shares of company stock valued at $7,669,416. Corporate insiders own 0.89% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Stock Observer and is the sole property of of Stock Observer. If you are viewing this news story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright law. The correct version of this news story can be accessed at https://www.thestockobserver.com/2018/01/13/strategy-asset-managers-llc-invests-2-68-million-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply